Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fiber and probiotics: a new hope for bloating and irregularity?

NCT ID NCT07755735

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether a daily fiber and probiotic supplement can improve gut health in adults who experience bloating, irregular bowel movements, and poor gut health. Over 12 weeks, participants take either the active supplement or a placebo twice a day. Researchers measure changes in gut symptoms, waist size, and body composition to see if the supplement makes a real difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A daily fiber and probiotic supplement containing acacia fiber, collagen peptides, and Bacillus coagulans
What this could lead to
If successful, this supplement could offer a simple, non-prescription way to ease bloating, improve regularity, and support overall gut health.
What could go wrong
This is a small, early-stage trial, and results may not apply to everyone. The supplement could cause digestive side effects, and any benefits might be modest or due to a placebo effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Aug 2025

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be male or female * Be aged 18 or older * Experiencing issues regarding all of the following over the past 4 weeks: bloating, irregular bowel movements, and self-perceived poor gut health * Generally healthy - does not live with any uncontrolled chronic disease * Willing to discontinue any other supplements or herbal remedies that target gut or digestive health * Not planning on introducing any products or any new forms of prescription medication or supplements that target gut health for the study duration * Willing to maintain current diet, sleep pattern, and activity levels for the duration * Resides in the United States * Not currently partaking in another research study and will not be partaking in any other research study for the next 12 weeks and at any point during this study's duration Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries * Anyone with any allergies or sensitivities to any of the study product ingredients * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period) * Anyone who is vegan and/or does not consume animal products for any reasons * Anyone unwilling to follow the study protocol * Anyone with a history of substance abuse

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bloating are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.